PYC Therapeutics Ltd
ASX:PYC
PYC Therapeutics Ltd
ASX:PYC
Price:
0.1 AUD
5.26%
Market Closed
Updated:
May 15, 2024
PYC Therapeutics Ltd
Interest Income Expense
|
PYC Therapeutics Ltd
Interest Income Expense Peer Comparison
Comparables:
IMM
MSB
CSL
CUV
TLX
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
PYC Therapeutics Ltd
ASX:PYC
|
Interest Income Expense
-AU$422.3k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Immutep Ltd
ASX:IMM
|
Interest Income Expense
AU$2.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
14%
|
|
|
Mesoblast Ltd
ASX:MSB
|
Interest Income Expense
-$18.4m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
N/A
|
|
|
CSL Ltd
ASX:CSL
|
Interest Income Expense
-$469m
|
CAGR 3-Years
-38%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
-25%
|
|
|
Clinuvel Pharmaceuticals Ltd
ASX:CUV
|
Interest Income Expense
-AU$3.5m
|
CAGR 3-Years
-17%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-40%
|
|
|
Telix Pharmaceuticals Ltd
ASX:TLX
|
Interest Income Expense
-AU$733k
|
CAGR 3-Years
60%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is PYC Therapeutics Ltd's Interest Income Expense?
Interest Income Expense
-422.3k
AUD
-422.3k
AUD
Based on the financial report for Dec 31, 2023, PYC Therapeutics Ltd's Interest Income Expense amounts to -422.3k AUD.
What is PYC Therapeutics Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 1Y
-990%
-990%
Over the last year, the Interest Income Expense growth was -990%.
You don't have any saved screeners yet
